The development of synthetic glucocorticoids
- 1 January 2001
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibition of VCAM-1 Expression in Human Bronchial Epithelial Cells by GlucocorticoidsAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- New steroidal anti-inflammatory antedrugs bind to macrophage glucocorticoid receptors and inhibit nitric oxide generationSteroids, 1998
- New steroidal anti-inflammatory antedrugs: Methyl 3,20-dioxo-9α-fluoro-11β,17α,21-trihydroxy-1,4-pregnadiene-16α-carboxylate and methyl 21-acetyloxy-3,20-dioxo-11β,17α-dihydroxy-9α-fluoro-1,4-pregnadiene-16α-carboxylateSteroids, 1997
- Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB SynthesisScience, 1995
- Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by GlucocorticoidsScience, 1995
- DeflazacortDrugs, 1995
- Steroidal anti-inflammatory antedrugs: Synthesis and pharmacological evaluation of 16α-alkoxycarbonyl-17-deoxyprednisolone derivativesSteroids, 1995
- A Comparison of Budesonide with Prednisolone for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.Proceedings of the National Academy of Sciences, 1994
- Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormoneCell, 1990